The short version
20 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Relafen Ds
Nabumetone · NABUMETONE 1000 mg/1 · Tablet · Oral · Carwin Pharmaceutical Associates, LLC
NDC 15370-0170-10 · 100 TABLET in 1 BOTTLE, PLASTIC · ANDA · View full market →
Medicare Part D
All Part D pricing →Matched to CMS's representative package for this drug (NDC 15370-0170-30) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.
ⓘ How this was built
Data sources
- CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method
Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
Plans pay at point of saleⓘ
$54.08per unit
middle half $53.89–$54.49 · 99 plans · Jul 1, 2024
Est. net of rebatesⓘ
≈ $54.08
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
—of plans cover it
*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 3 quarters since 2024.
NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for nabumetone (oral solid) in the next 90 days
sole-source market · price up 2% YoY
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill · avg $3,518.88 per prescription
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- ANDA203166
- TE code
- AB
- Approval date
- Aug 30, 2019
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Nabumetone (Tablet)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Bryant Ranch Prepack | NABUMETONE 500 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Bryant Ranch Prepack | NABUMETONE 750 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Proficient Rx LP | NABUMETONE 750 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| A-S Medication Solutions | NABUMETONE 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| A-S Medication Solutions | NABUMETONE 750 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Advanced Rx of Tennessee, LLC | NABUMETONE 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Advanced Rx Pharmacy of Tennessee, LLC | NABUMETONE 750 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Asclemed Usa Inc. | NABUMETONE 750 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Asclemed USA, Inc. | NABUMETONE 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Carwin Pharmaceutical Associates, LLC | NABUMETONE 1000 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| direct rx | NABUMETONE 750 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| direct rx | NABUMETONE 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Northwind Health Company, LLC | NABUMETONE 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Northwind Health Company, LLC | NABUMETONE 750 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Preferred Pharmaceuticals Inc. | NABUMETONE 750 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Preferred Pharmaceuticals, Inc. | NABUMETONE 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Proficient Rx LP | NABUMETONE 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Quality Care Products, LLC | NABUMETONE 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Quality Care Products, LLC | NABUMETONE 750 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Redpharm Drug | NABUMETONE 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Remedyrepack Inc. | NABUMETONE 750 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Remedyrepack Inc. | NABUMETONE 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| ScieGen Pharmaceuticals Inc | NABUMETONE 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| ScieGen Pharmaceuticals Inc | NABUMETONE 750 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Sportpharm LLC | NABUMETONE 750 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Sportpharm LLC | NABUMETONE 500 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| St. Mary's Medical Park Pharmacy | NABUMETONE 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| St. Mary's Medical Park Pharmacy | NABUMETONE 750 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Westminster Pharmaceuticals, LLC | NABUMETONE 750 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Westminster Pharmaceuticals, LLC | NABUMETONE 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| PD-Rx Pharmaceuticals, Inc. | NABUMETONE 750 mg/1 | Jul 15, 2026 | Aug 28, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Relafen Ds — NDC 15370-0170-10," retrieved September 3, 2026, https://drugdashboards.com/drug/15370017010.
Free to cite with attribution — see how the data is put together.